156 related articles for article (PubMed ID: 7493397)
1. Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization.
Ullén A; Riklund Ahlström K; Makiya R; Stigbrand T
Cell Biophys; 1995 Aug; 27(1):31-45. PubMed ID: 7493397
[TBL] [Abstract][Full Text] [Related]
2. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
[TBL] [Abstract][Full Text] [Related]
3. Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargeting.
Sandström P; Johansson A; Ullén A; Rathsman S; Riklund-Ahlström K; Stigbrand T
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3073s-3078s. PubMed ID: 10541346
[TBL] [Abstract][Full Text] [Related]
4. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
[TBL] [Abstract][Full Text] [Related]
5. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
[TBL] [Abstract][Full Text] [Related]
7. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
[TBL] [Abstract][Full Text] [Related]
8. Tumor radioimmunolocalization in nude mice by mono- and divalent- single-chain Fv antiplacental alkaline phosphatase antibodies.
Sheikholvaezin A; Eriksson D; Ahlström KR; Johansson L; Stigbrand T
Cancer Biother Radiopharm; 2007 Feb; 22(1):64-72. PubMed ID: 17627415
[TBL] [Abstract][Full Text] [Related]
9. Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapy.
Ullén A; Ahlström KR; Heitala S; Nilsson B; Arlestig L; Stigbrand T
Acta Oncol; 1996; 35(3):281-5. PubMed ID: 8679257
[TBL] [Abstract][Full Text] [Related]
10. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
[TBL] [Abstract][Full Text] [Related]
11. Improved radioimmunoscintigraphy of human mammary carcinoma xenografts after injection of an anti-antibody.
Senekowitsch R; Bode W; Reidel G; Glässner H; Möllenstädt S; Kriegel H; Pabst HW
Nuklearmedizin; 1987 Feb; 26(1):13-9. PubMed ID: 3495786
[TBL] [Abstract][Full Text] [Related]
12. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
[TBL] [Abstract][Full Text] [Related]
13. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro interactions between idiotypic and antiidiotypic monoclonal antibodies against placental alkaline phosphatase.
Ullén A; Nilsson B; Ahlström KR; Makiya R; Stigbrand T
J Immunol Methods; 1995 Jun; 183(1):155-65. PubMed ID: 7541429
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic analysis of anti-I-Ak monoclonal antibodies. III. T- and B-cell responses to anti-Ia idiotopes are not modulated by syngeneic anti-idiotypic monoclonal antibodies.
Phillips ML; Delovitch TL
Cell Immunol; 1985 Dec; 96(2):363-75. PubMed ID: 3879805
[TBL] [Abstract][Full Text] [Related]
16. Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumour localisation of murine monoclonal antibodies and fragments.
Pimm MV; Gribben SJ
Anticancer Res; 1993; 13(1):241-8. PubMed ID: 8476219
[TBL] [Abstract][Full Text] [Related]
17. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
[TBL] [Abstract][Full Text] [Related]
18. Protection against a syngeneic mammary adenocarcinoma by administration of idiotypic and anti-idiotypic antibodies.
Myers WL; el-Zein A
Immunol Invest; 1989 Oct; 18(8):937-50. PubMed ID: 2583749
[TBL] [Abstract][Full Text] [Related]
19. Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice.
Pimm MV; Gribben SJ
J Cancer Res Clin Oncol; 1992; 119(1):41-5. PubMed ID: 1400564
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the repertoire of anti-idiotypic B-cell responses to self-I-Ak- or -I-Ek-reactive monoclonal antibodies in A.TL mice.
Devaux C; Pierres M
Scand J Immunol; 1983 Apr; 17(4):375-87. PubMed ID: 6601297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
